Abstract
Intravesical administration of agents for the treatment of superficial bladder cancer often cause urological side effects (urgency, frequency, dysuria) and for doxorubicin these adverse effects are associated with enhanced urothelial contractions and also enhanced neurogenic detrusor contraction. Intravesical
Original language | English |
---|---|
Pages | 205-205 |
Number of pages | 1 |
Publication status | Published - 2012 |
Event | Joint ASCEPT- APSA 2012 Conference : Medication Safety - Sydney Convention and Exhibition Centre, Sydney, Australia Duration: 2 Dec 2012 → 5 Dec 2012 http://www.ascept-apsa.com/ |
Conference
Conference | Joint ASCEPT- APSA 2012 Conference |
---|---|
Country/Territory | Australia |
City | Sydney |
Period | 2/12/12 → 5/12/12 |
Internet address |